SteadMed

Fort Worth, United States Founded: 2010 • Age: 16 yrs
Wound, skin and incontinence therapy products

About SteadMed

SteadMed is a company based in Fort Worth (United States) founded in 2010.. SteadMed has raised $3.08 million across 1 funding round. The company has 130 employees as of December 31, 2023. SteadMed operates in a competitive market with competitors including QBiotics, MediWound, Ilya Pharma, Resolution Therapeutics and ProFibrix, among others.

  • Headquarter Fort Worth, United States
  • Employees 130 as on 31 Dec, 2023
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Urgo Medical North America Llc
Operational Areas
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $3.08 M (USD)

    in 1 rounds

  • Latest Funding Round
    $3.08 M (USD), Series A

    Jun 28, 2011

  • Investors
  • Employee Count
    130

    as on Dec 31, 2023

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of SteadMed
Headcount 10-50
Employee Profiles 57
Employee Profiles
People
Derek Murphy
Senior Account Manager And Field Sales Trainer
People
Michelle Spiewak
Wound Care Account Manager
People
Chad Mouledous
District Sales Manager
People
Samantha Rivera
Senior Account Manager And Field Sales Trainer

Unlock access to complete

Funding Insights of SteadMed

SteadMed has successfully raised a total of $3.08M through 1 strategic funding round. The most recent funding activity was a Series A round of $3.08 million completed in June 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series A — $3.1M
  • First Round

    (28 Jun 2011)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2011 Amount Series A - SteadMed Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by SteadMed

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - SteadMed

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Steadmed Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of SteadMed

SteadMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as QBiotics, MediWound, Ilya Pharma, Resolution Therapeutics and ProFibrix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Small molecules from plant extracts are developed for medical applications.
domain founded_year HQ Location
Enzymatic therapies for tissue repair and regeneration are developed.
domain founded_year HQ Location
Biological drugs for skin and mucosa wound treatment are developed.
domain founded_year HQ Location
Macrophage cell therapies are developed for inflammatory and liver diseases.
domain founded_year HQ Location
Powdered fibrin sealant for surgical bleeding
domain founded_year HQ Location
Topical formulations for corneal wounds, ulcers, and scars are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Steadmed

Frequently Asked Questions about SteadMed

When was SteadMed founded?

SteadMed was founded in 2010 and raised its 1st funding round 1 year after it was founded.

Where is SteadMed located?

SteadMed is headquartered in Fort Worth, United States. It is registered at Fort Worth, Texas, United States.

Is SteadMed a funded company?

SteadMed is a funded company, having raised a total of $3.08M across 1 funding round to date. The company's 1st funding round was a Series A of $3.08M, raised on Jun 28, 2011.

How many employees does SteadMed have?

As of Dec 31, 2023, the latest employee count at SteadMed is 130.

What does SteadMed do?

SteadMed Medical has a portfolio of products catering to acute and chronic wounds, skin and incontinence care. They also partner with other technology companies to market their products in North America. They work with wound care centres, hospitals, home health agencies and nursing homes.

Who are the top competitors of SteadMed?

SteadMed's top competitors include Ilya Pharma, QBiotics and Tempo Therapeutics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available